NCI’s Consumer Liaison Group Chooses Four Areas of Concern

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 3
Volume 7
Issue 3

BETHESDA, Md--The new consumer liaison group to the NCI director has chosen three of its 15 members to serve as co-chairs and has identified four areas of concern for its initial attention.

BETHESDA, Md--The new consumer liaison group to the NCI director has chosen three of its 15 members to serve as co-chairs and has identified four areas of concern for its initial attention.

The co-chairs are M. Venus Gines, a breast-cancer survivor from Lithonia, Ga, active in community work with the American Cancer Society; Susan A. Leigh of Tucson, Ariz, a survivor of Hodgkin’s disease, breast cancer, and bladder cancer, and active in the National Coalition for Cancer Survivorship and the Oncology Nursing Society; and Daniel M. Moore, Jr., a prostate cancer survivor from Decatur, Ill, who started the Central Illinois US TOO! prostate cancer support group.

The consumer group’s four areas of immediate concern are communications and immediate access to reliable cancer information; informed consent, including making forms more understandable; patient consumer issues and population and genetics studies; and ways to identify additional consumer representatives for NCI committees and groups.

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content